Caplin Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CAPLIN, and what generic and branded alternatives to CAPLIN drugs are available?
CAPLIN has twenty approved drugs.
There is one tentative approval on CAPLIN drugs.
Drugs and US Patents for Caplin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caplin | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 217725-001 | Jun 9, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Caplin | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 217725-002 | Jun 9, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Caplin | KETOROLAC TROMETHAMINE | ketorolac tromethamine | SOLUTION/DROPS;OPHTHALMIC | 218204-001 | Mar 26, 2024 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Caplin | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 215028-001 | Dec 18, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for CAPLIN drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
Similar Applicant Names
Here is a list of applicants with similar names.